Cargando…
Oral bioavailability of cantharidin-loaded solid lipid nanoparticles
BACKGROUND: The clinical application of cantharidin (CA) is limited by its insolubility, toxicity and short half-life in circulation. This study aims to achieve a steady and sustained blood concentration–time profile, using solid lipid nanoparticles (SLNs) as a drug carrier. METHODS: CA-SLNs were pr...
Autores principales: | Dang, Yun-Jie, Zhu, Chun-Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615953/ https://www.ncbi.nlm.nih.gov/pubmed/23298453 http://dx.doi.org/10.1186/1749-8546-8-1 |
Ejemplares similares
-
Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles
por: Alsulays, Bader B, et al.
Publicado: (2019) -
Development of Glycyrrhetinic Acid and Folate Modified Cantharidin Loaded Solid Lipid Nanoparticles for Targeting Hepatocellular Carcinoma
por: Xu, Yilin, et al.
Publicado: (2022) -
Development and characterization of solid lipid nanoparticles for enhancement of oral bioavailability of Raloxifene
por: Patel, B. Divyakant, et al.
Publicado: (2012) -
Preparation, Characterization and Evaluation of Quetiapine Fumarate Solid Lipid Nanoparticles to Improve the Oral Bioavailability
por: Narala, Arjun, et al.
Publicado: (2013) -
Solid lipid nanoparticles with enteric coating for improving stability, palatability, and oral bioavailability of enrofloxacin
por: Li, Chao, et al.
Publicado: (2019)